75A50121C00030
Definitive Contract
Overview
Government Description
FIRSTSTRING RESEARCH, INC.: REPURPOSING DRUGS IN RESPONSE TO CHEMICAL THREATS (REDIRECT)
Awardee
Awarding / Funding Agency
Place of Performance
Mount Pleasant, SC 29464 United States
Pricing
Fixed Price
Set Aside
None
Extent Competed
Full And Open Competition
Est. Average FTE
1
Related Opportunity
Analysis Notes
Amendment Since initial award the Potential End Date has been extended from 05/31/22 to 10/31/23 and the Potential Award value has increased 1% from $742,500 to $749,999.
Predecessor This appears to be a continuation of a prior contract 75A50120C00111.
Predecessor This appears to be a continuation of a prior contract 75A50120C00111.
Xequel Bio was awarded
Definitive Contract 75A50121C00030 (75A501-21-C-00030)
for Firststring Research, Inc.: Repurposing Drugs In Response To Chemical Threats (REDIRECT)
worth up to $749,999
by the HHS Office of the Assistant Secretary for Preparedness and Response
in March 2021.
The contract
has a duration of 2 years 7 months and
was awarded
through solicitation BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement
full & open
with
NAICS 541714 and
PSC AN13
via basic research acquisition procedures with 1 bid received.
Status
(Complete)
Last Modified 8/14/23
Period of Performance
3/25/21
Start Date
10/31/23
Current End Date
10/31/23
Potential End Date
Obligations
$750.0K
Total Obligated
$750.0K
Current Award
$750.0K
Potential Award
Award Hierarchy
Definitive Contract
75A50121C00030
Subcontracts
Activity Timeline
Opportunity Lifecycle
Procurement history for 75A50121C00030
Transaction History
Modifications to 75A50121C00030
People
Suggested agency contacts for 75A50121C00030
Competition
Number of Bidders
1
Solicitation Procedures
Basic Research
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Awardee UEI
T4JKC8B27PJ7
Awardee CAGE
4GLF5
Agency Detail
Awarding Office
75A501 BARDA - ASPR / DAAPPO / BARDA DCMA
Funding Office
75A501
Created By
hhsbushra_rasheed
Last Modified By
anna.chiang@hhs.gov
Approved By
anna.chiang@hhs.gov
Legislative
Legislative Mandates
None Applicable
Performance District
SC-01
Senators
Lindsey Graham
Tim Scott
Tim Scott
Representative
Nancy Mace
Modified: 8/14/23